< Back to companies42
New therapy for metastatic medullary thyroid carcinoma (MTC)
AZ
MTC is a rare, incurable disease. Synactix is dedicated to creating safer, more effective treatment options to patients in need.
Company Info
Categories
BiotechCancerDrug Discovery/DevelopmentRare DiseasesPrecision Medicine
Video
MedStartr Index Score
?What do you think of New therapy for metastatic medullary thyroid carcinoma (MTC)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.